Key Statistics for SBS
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (EUR) (ttm)
|Est. EPS (EUR) (12/2013)
|Est. PEG Ratio
|Market Cap (M EUR)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (EUR)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for SBS
- Net Income (M/EUR)
STRATEC Biomedical AG develops, manufactures and markets automated equipment and systems for the analysis of chemical and biological compounds. The Company's systems are used primarily for the analysis of blood and other fluids and include luminometers, fluorometers and pipette systems. Stratec markets its products worldwide.
More Company Profile & Key Executives for SBS
|Marcus WolfingerChairman-Mgmt Board||Bernd M SteidleMember-Mgmt Board:Sales & Mktg|
|Robert SiegleMember-Mgmt Board:HR|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.